MML Investors Services’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.25M Buy
80,829
+11,543
+17% +$179K ﹤0.01% 1531
2025
Q1
$1.03M Buy
69,286
+7,133
+11% +$106K ﹤0.01% 1550
2024
Q4
$823K Buy
62,153
+21,055
+51% +$279K ﹤0.01% 1633
2024
Q3
$584K Buy
41,098
+4,485
+12% +$63.7K ﹤0.01% 1770
2024
Q2
$474K Sell
36,613
-7,288
-17% -$94.4K ﹤0.01% 1822
2024
Q1
$610K Sell
43,901
-91
-0.2% -$1.26K ﹤0.01% 1690
2023
Q4
$628K Buy
43,992
+5,229
+13% +$74.6K ﹤0.01% 1623
2023
Q3
$600K Buy
38,763
+11,053
+40% +$171K ﹤0.01% 1514
2023
Q2
$435K Buy
27,710
+7,998
+41% +$126K ﹤0.01% 1721
2023
Q1
$325K Sell
19,712
-8,130
-29% -$134K ﹤0.01% 1632
2022
Q4
$434K Buy
27,842
+3,338
+14% +$52K ﹤0.01% 1575
2022
Q3
$318K Buy
24,504
+3,008
+14% +$39K ﹤0.01% 1648
2022
Q2
$302K Buy
21,496
+627
+3% +$8.81K ﹤0.01% 1683
2022
Q1
$299K Buy
20,869
+998
+5% +$14.3K ﹤0.01% 1731
2021
Q4
$271K Sell
19,871
-4,134
-17% -$56.4K ﹤0.01% 1755
2021
Q3
$393K Buy
24,005
+142
+0.6% +$2.33K ﹤0.01% 1485
2021
Q2
$402K Sell
23,863
-13,536
-36% -$228K ﹤0.01% 1443
2021
Q1
$683K Buy
37,399
+4,404
+13% +$80.4K 0.01% 1101
2020
Q4
$601K Buy
32,995
+4,453
+16% +$81.1K 0.01% 1064
2020
Q3
$509K Buy
28,542
+1,560
+6% +$27.8K 0.01% 1035
2020
Q2
$484K Sell
26,982
-1,092
-4% -$19.6K 0.01% 1009
2020
Q1
$426K Buy
28,074
+9,284
+49% +$141K 0.01% 944
2019
Q4
$371K Buy
18,790
+2,448
+15% +$48.3K 0.01% 1129
2019
Q3
$281K Buy
16,342
+1,995
+14% +$34.3K ﹤0.01% 1221
2019
Q2
$254K Buy
14,347
+2,781
+24% +$49.2K ﹤0.01% 1383
2019
Q1
$236K Buy
+11,566
New +$236K ﹤0.01% 1395